Citadel Advisors’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
RA
IH
ACM
Citadel Advisors's TBI Position: Q2 2026 in Review
Citadel Advisors sold out of Trueblue (TBI) in Q2 2026, closing a stake of 32,617 shares — an estimated $128K sold.
Citadel Advisors first reported a position in TBI in Q2 2013 and held it in 46 quarters. The position peaked at $8.35M in Q1 2024. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.
- Citadel Advisors reported no remaining Trueblue position as of Q2 2026 after selling out during the quarter.
- Citadel Advisors sold 32,617 Trueblue shares in Q2 2026, an estimated $128K.
- Citadel Advisors first reported a position in Trueblue in Q2 2013 and held it in 46 quarters.
- Citadel Advisors's Trueblue position peaked at $8.35M in Q1 2024.
- 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.